Promise of Fast Growth Propels Molecular Technologies in Fighting Infections

Promise of Fast Growth Propels Molecular Technologies in Fighting Infections

Molecular infectious disease tests detect active and latent patient infections by targeting genetic sequences specific to pathogens, typically bacteria or viruses, but also fungi and parasites. Tests that utilize these methods experience faster revenue growth and will compete better on the world market, according to Kalorama's recent study on the molecular infectious disease testing market.


What are the Growth Markets in the Hospital Infection Control Industry?

What are the Growth Markets in the Hospital Infection Control Industry?

The scourge of hospital-acquired-infections (HAIs) will drive market growth for infection control in three segments. Devices that can test for HAIs, equipment to clean and sterilize facilities and devices, and drugs that can treat these threats.


Luminex Acquisition of Nanosphere Continues Trend of Investment in Decentralized Molecular Testing

Luminex Acquisition of Nanosphere Continues Trend of Investment in Decentralized Molecular Testing

This blog post reviews the recent history of acquisitions and investment in the area of decentralized molecular diagnostics. Kalorama Information’s The Market and Potential for Molecular Point of Care Diagnostics provides the current market, projected future sales and total available markets in 2020 for molecular POC diagnostics for flu, strep A, RSV, CT/NG, group B strep (GBS), HPV, HSV, vaginitis, HIV, TB, hepatitis, malaria and many other disease areas.

On May 16, Luminex Corporation announ...


Cepheid, Others Look Beyond Respiratory Infections in the Molecular POC Diagnostics Market

Companies looking beyond the clinical lab in the molecular diagnostics market predominately target rapid test demand in primary care and critical care, chiefly respiratory infections. All CLIA waivers to date for molecular tests have been for respiratory infections (influenza, strep A, RSV), though equally ample and more promising markets for molecular point-of-care (POC) diagnostics market will be found in other areas - including women’s health/sexual health and high-burden diseases in the deve...


Early Implications of the Zika Virus for the U.S. Diagnostics Market

Early Implications of the Zika Virus for the U.S. Diagnostics Market

In addition to its blog posts regarding infectious disease threats, Kalorama Information offers a comprehensive market research report for global infectious disease testing.

Since the last blog entry regarding Zika virus diagnostics, the U.S. Centers for Disease Control and Prevention (CDC) has issued emergency use authorizations (EUA) for a Zika IgM Antibody Capture ELISA (MAC-ELISA) kit and real-time reverse transcriptase PCR (RT-PCR) kit. Controls and kit reagents are available through the ...


WHO Study Explores Environmental Factors Behind Diseases with Significant IVD Markets

WHO Study Explores Environmental Factors Behind Diseases with Significant IVD Markets

Amidst rising threats posed by climate change and inadequate utilites infrastructure even in the developed world , the World Health Organization (WHO) released the second edition of its decadal global assessment of diseases impacted by environmental risks. The comprehensive WHO study summates the fraction of deaths and morbidity attributable to environmental factors such as air, water and soil pollution; radiation; occupational risks; built environments; agricultural methods; and climate and eco...


qPCR? dPCR? From Anywhere? They’ve Got an App for That in Infectious Disease Testing

qPCR? dPCR? From Anywhere? They’ve Got an App for That in Infectious Disease Testing

This blog post reviews molecular point-of-care (POC) diagnostic platforms included in the most recent edition of the report The Market and Potential for Molecular Point of Care Diagnostics. Kalorama Information offers related titles with qPCR and dPCR Markets , The World Market for Infectious Disease Diagnostic Tests , and The World Market for Molecular Diagnostics.

Contributing a high amount of growth to the clinical IVD market over the past decade, molecular diagnostics is established in ref...


Infectious Disease Updates - Zika Virus, Lyme Disease and the U.S. Influenza Season

Infectious Disease Updates - Zika Virus, Lyme Disease and the U.S. Influenza Season

Kalorama Information offers complete analysis of the global infectious disease diagnostics market with its recent title The World Market for Infectious Disease Diagnostic Tests. Previous posts in this blog reviewed infectious disease test market segments for hospital-acquired infections (HAIs); antimicrobial resistance ; women’s health and sexually transmitted pathogens , hepatitis , HIV/AIDS , and respiratory tract infection tests.

Influenza in the United States

The United States is experie...


Leading Infectious Diseases in the IVD Market - Healthcare-Acquired Infections and Antimicrobial Resistance

Leading Infectious Diseases in the IVD Market - Healthcare-Acquired Infections and Antimicrobial Resistance

The following analysis is derived from Kalorama Information’s recently released global market research report: The Worldwide Market for Infectious Disease Diagnostic Tests. A more comprehensive report on markets for the control of hospital-acquired infections, including sterilization, disinfection, testing and treatment is also available with The Market for Hospital-Acquired Infection Control.

This is the final post in a series of five outlining the leading infectious diseases or infectious di...


Leading Infectious Diseases in the IVD Market - Women’s Health and Sexually Transmitted Infections

Leading Infectious Diseases in the IVD Market - Women’s Health and Sexually Transmitted Infections

The following analysis is derived from Kalorama Information’s recently released global market research report: The Worldwide Market for Infectious Disease Diagnostic Tests. A more comprehensive report on assorted women’s health diagnostics, including non-infectious disease tests, is available with Diagnostic Markets for Women’s Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI and Other Testing).

This is the fourth in a ...